Novel Lomefloxacin-Triazole Hybrids: Design, Synthesis and In Vitro Antiproliferative Activity in Breast, Melanoma and Colon Cancer Cell Lines.

Nowakowska J, Rzepka Z, Bak A, Wrześniok D, Marciniec K

Open source

DOI
10.3390/biom16091323
Published
2026 Sep 11
Container
Biomolecules
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biom16091323,
  title = {Novel Lomefloxacin-Triazole Hybrids: Design, Synthesis and In Vitro Antiproliferative Activity in Breast, Melanoma and Colon Cancer Cell Lines.},
  author = {Nowakowska J and Rzepka Z and Bak A and Wrześniok D and Marciniec K},
  year = {2026},
  journal = {Biomolecules},
  doi = {10.3390/biom16091323},
  url = {https://doi.org/10.3390/biom16091323}
}

RIS

TY  - JOUR
TI  - Novel Lomefloxacin-Triazole Hybrids: Design, Synthesis and In Vitro Antiproliferative Activity in Breast, Melanoma and Colon Cancer Cell Lines.
AU  - Nowakowska J
AU  - Rzepka Z
AU  - Bak A
AU  - Wrześniok D
AU  - Marciniec K
PY  - 2026
JO  - Biomolecules
DO  - 10.3390/biom16091323
UR  - https://doi.org/10.3390/biom16091323
ER  - 

APA

J, N., Z, R., A, B., D, W., & K, M. (2026). Novel Lomefloxacin-Triazole Hybrids: Design, Synthesis and In Vitro Antiproliferative Activity in Breast, Melanoma and Colon Cancer Cell Lines.. Biomolecules. https://doi.org/10.3390/biom16091323

Source records